Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1b Study of QX1206 in Type 2 Diabetes Mellitus (T2DM) Patients With Non-Alcoholic Fatty Liver Disease (NAFLD)

NCT06694935 is registered in ClinicalTrials.gov with 1Globe Health Institute as lead sponsor.

NCT NCT06694935
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06694935 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1b Study of QX1206 in Type 2 Diabetes Mellitus (T2DM) Patients With Non-Alcoholic Fatty Liver Disease (NAFLD)
Lead sponsor
1Globe Health Institute
Phase
Phase 1
Overall status
Recruiting
Start date
January 6, 2025
Completion date
December 31, 2025
Enrollment
52 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

non-alcoholic fatty liver disease (nafld), type 2 diabetes mellitus (t2dm)